Health
Risk not stated by sourcePar Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presence of Particulate Matter
FDA14 Oct 2026
Brand match
Par Health And Endo
Markets
US
United States Health recalls
Latest official safety notices for United States.
What this United States health recalls feed covers
This page lists health recalls and safety alerts from official sources relevant to United States. Each notice links back to the original official source.
Start with a recall below to review the affected products, identifiers and dates, then follow the action described in the official notice.
RecallScope is not affiliated with any government agency or regulator — we list what official public sources publish, so always check the original notice before acting on an alert.
Where these recalls come from
Updated from official United States public sources. Always open the original notice for the full product list.
Latest United States Health recalls
Most recent safety alerts, newest first.
Risk not stated by sourceHealth
Risk not stated by sourcePar Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg vial CIV (Methohexital Sodium for Injection, USP) Due
FDA9 Oct 2026
Brand match
Par Pharmaceutical
Markets
US
Health
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC
FDA7 Oct 2026
Brand match
Ajanta Pharma
Markets
US
Health
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Estradiol Gel, 0.1%, 0.25 mg, 30-packets per carton, Rx only
FDA7 Oct 2026
Brand match
Amneal Pharmaceuticals
Markets
US
Health
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE
FDA7 Oct 2026
Brand match
Aurolab Trust
Markets
US
Health
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only
FDA7 Oct 2026
Brand match
Tersera Therapeutics
Markets
US
Health
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Buprenorphine Hydrochloride, Injection 0.3 mg mL, Rx Only, 5 x 1 mL Single Dose Vials
FDA7 Oct 2026
Brand match
Par Health
Markets
US
Health
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only
FDA7 Oct 2026
Brand match
Apotex
Markets
US
Frequently asked questions
A recall is an official notice that a product may create a safety risk or does not meet a required standard. The notice explains which products are affected and what action to take.
Open the recall and compare its product name, model, batch, serial number, VIN or other identifiers with the item you own.
Follow the action in the official notice. Depending on the recall, this may mean stopping use, returning the product, contacting the supplier or booking a repair.